Skip to content

Pharma Petite Suisse

Active
Private limited companyfounded 2018active for 7 yearsBoondaalse Steenweg 312, 1050 Elsene, BelgiumKBO/BCE: BE 0715.975.212
Summary

Pharma Petite Suisse has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €42,146 and a net result of €80,315. Equity has been growing by about 16% per year since 2019. Its solvency ranks better than 17% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).

Overview

Official details

Source: KBO
Status
Active since 18-12-2018 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.282.911.430 1050 Elsene, since 01-01-2019
Financial year end
31 December
Peppol
Reachable since 27-11-2025

Board and ownership

Board
  • LE NhuDirector · since 18-12-2018

Financial position

65 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.2%
Annual accounts 2025
Gross margin
€314,507
▲ 3.6%
Turnover
≈ €1.1m
estimated
Profit
€80,315
▲ 6.7%
Equity
€42,146
▲ 0.8%
Total assets
€776,775
▼ 3.1%
Employees on 31-12-2025
2
▼ 33.3%
Score breakdownraises riskEquity €42,146 (5.4% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: 2.3 FTE, total assets €776,775Figures for financial year 2025 (filed on 09-06-2026)Show the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 43% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 30=
equity 5.4% of total assets
Liquidity 36-3
short-term debt 40.8% · cash 4.0%
Profitability 82+2
return on assets 10.3%
Bankruptcy probability within 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 1.7% 01-2025: 1.7%● unchanged vs 12-2024 02-2025: 1.7%● unchanged vs 01-2025 03-2025: 1.6%▼ -0.1 percentage points vs 02-2025 04-2025: 1.6%● unchanged vs 03-2025 05-2025: 1.6%● unchanged vs 04-2025 06-2025: 1.7%▲ +0.1 percentage points vs 05-2025 07-2025: 1.8%▲ +0.1 percentage points vs 06-2025 08-2025: 2.5%▲ +0.7 percentage points vs 07-2025highest value 09-2025: 1.3%▼ -1.2 percentage points vs 08-2025 10-2025: 1.3%● unchanged vs 09-2025 11-2025: 1.3%● unchanged vs 10-2025 12-2025: 1.3%● unchanged vs 11-2025 01-2026: 1.3%● unchanged vs 12-2025 02-2026: 1.3%● unchanged vs 01-2026 03-2026: 1.3%● unchanged vs 02-2026 04-2026: 1.4%▲ +0.1 percentage points vs 03-2026 05-2026: 1.4%● unchanged vs 04-2026 06-2026: 1.5%▲ +0.1 percentage points vs 05-2026 07-2026: 1.3%▼ -0.2 percentage points vs 06-2026 08-2026: 1.3%● unchanged vs 07-2026 09-2026: 1.2%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: 1.2%● unchanged vs 09-2026lowest value 11-2026: 1.2%● unchanged vs 10-2026lowest value
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.81 (0.9 in 2024), below 1. Short-term debt is 40.8% and cash 4% of total assets. 94.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 23% of them on solvency, 33% on liquidity, 74% on profitability and 42% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €42,146 (5.4% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 2.3 FTE, total assets €776,775
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 09-06-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 12775 sector peers (2025).
NBB · sector comparison
Position among 12775 sector peers
Solvency
better than 17%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
52 days early
2024
1 day early
2023
22 days late
2022
28 days late
2021
18 days early
2020
26 days late
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 4 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 83% of companies in retail tradesector median 36.6% · 12,775 companies 5.4% View
  • Positive: 6 profitable years in a rowprofit 2025: €80,315 6 years View

Recent changes

  1. · Gazette deed Reappointment: LE Nhu (director)
  2. · Gazette deed Incorporation
All 12 events

Comparable companies

These companies have the same main activity as Pharma Petite Suisse: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €730,000 and €806,000, founded between 2016 and 2020.

CompanyTotal assetsGross margin
Pharma Petite Suisse Elsene€776,775€314,507
APOTHEEK MEES GEETBETS Geetbets€777,058€307,519
NORDPHARMA Brussel€784,352€279,900
WIJMENPUT Aalst€805,856€289,996
PHARMACIE DETREZ Ham-sur-Heure-Nalinnes€798,871€350,855
Pharmaplus Detimmerman Tournai€803,004€340,996
PHARMA GONRIEUX Viroinval€730,175€261,102
Full comparison

Key facts about Pharma Petite Suisse

What is the company number of Pharma Petite Suisse?
The company number of Pharma Petite Suisse is 0715.975.212. The VAT number is the same number with BE in front: BE 0715.975.212.
Where is Pharma Petite Suisse based?
The registered office is at Boondaalse Steenweg 312, 1050 Elsene.Company details
What does Pharma Petite Suisse do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Pharma Petite Suisse?
The legal form of Pharma Petite Suisse is Private limited company (BV).
When was Pharma Petite Suisse founded?
Pharma Petite Suisse was founded on 18-12-2018.
Is Pharma Petite Suisse still active?
Yes, Pharma Petite Suisse is an active enterprise in the KBO register.
How many employees does Pharma Petite Suisse have?
Pharma Petite Suisse had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Pharma Petite Suisse?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €314,507 and 47 comparable companies (NACE 477). It probably lies between €890,000 and €1.9m.
Is Pharma Petite Suisse profitable?
In financial year 2025, Pharma Petite Suisse made a profit of €80,315.
Where can I find the annual accounts of Pharma Petite Suisse?
Pharma Petite Suisse filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Pharma Petite Suisse due?
Pharma Petite Suisse must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.